Osteoarthritis year in review 2024: Genetics, genomics, and epigenetics
Osteoarthritis and Cartilage · 2025-01 · 33 (1) · 50-57
DOI: 10.1016/j.joca.2024.10.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Osteoarthritis and Cartilage, 2025-01. Verfasst von Cindy G Boer. Beteiligte Einrichtung: Department of Internal Medicine, Genomics Medicine Center, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: c.b…. Hauptthemen laut MEDLINE: Osteoarthritis, Genomics. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ReumaNederland.
Abstract (Originalsprache)
OBJECTIVE: The purpose of this narrative review is to highlight the advances made in the past 12 months in the field of osteoarthritis genetics, genomics and epigenetics. METHODS: The Medline and Embase databases were systematically searched for original publications using terminology, and combinations of terminology, relating to: "osteoarthritis", "genetics", "genomics", and "epigenetics". Only original research articles published in the English language between the OARSI congresses of April 2032 and April 2024 were considered. RESULTS: This narrative review focuses only on studies using genome-wide omics techniques in human material. There was a rise in functional genomics studies across different osteoarthritis-relevant tissues, which have robustly identified an additional 26 genes involved in osteoarthritis pathology. Two of such previously identified genes (MGP, ALDH1A2) are currently the target of ongoing clinical trials for osteoarthritis. This past year also saw the use of single-cell transcriptomics and two relatively new omics: epitranscriptomics and mitochondrial genomics. CONCLUSION: This past year of genomics research has led to multiple exciting findings involving genes and mechanisms linked to osteoarthritis. Moreover, the comprehensive genome-wide omics datasets generated for diverse osteoarthritis tissues will prove invaluable for future research aimed at elucidating more causal biological mechanisms and possible therapeutic targets for osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Genomics Medicine Center, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: c.boer@erasmusmc.nl.
Förderung
- ReumaNederland
Zitieren
APA
Boer, C. G. (2025). Osteoarthritis year in review 2024: Genetics, genomics, and epigenetics. Osteoarthritis and Cartilage, 33(1), 50-57. https://doi.org/10.1016/j.joca.2024.10.014
Vancouver
Boer CG. Osteoarthritis year in review 2024: Genetics, genomics, and epigenetics. Osteoarthritis and Cartilage. 2025;33(1):50-57. doi:10.1016/j.joca.2024.10.014
BibTeX
@article{Boer2025,
author = {Boer, Cindy G},
title = {Osteoarthritis year in review 2024: Genetics, genomics, and epigenetics},
journal = {Osteoarthritis and Cartilage},
year = {2025},
volume = {33},
number = {1},
pages = {50--57},
doi = {10.1016/j.joca.2024.10.014}
}
EUVIMED